Skip to main content
SpringerLink
Log in

Changing the name of diabetes insipidus

  • Published:
Pituitary Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Not applicable.

References

  1. Venturini PL, Capitanio GL, Boccardo E, Ferraro R, Rossato P, De CL (1975) The amenorrhoea-galactorrhea syndrome: present diagnostic and therapeutic perspectives. Acta Eur Fertil 6(4):331–338

    PubMed  CAS  Google Scholar 

  2. Matteson EL (2000) Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schonlein, Wegener, Churg and Strauss, Horton, Takayasu, Behcet, and Kawasaki. Arthritis Care Res 13(4):237–245

    Article  PubMed  CAS  Google Scholar 

  3. Lu DW, Katz KA (2005) Declining use of the eponym “Reiter’s syndrome” in the medical literature, 1998–2003. J Am Acad Dermatol 53(4):720–723

    Article  PubMed  Google Scholar 

  4. Woywodt A, Haubitz M, Haller H, Matteson EL (2006) Wegener’s granulomatosis. Lancet 367(9519):1362–1366

    Article  PubMed  Google Scholar 

  5. Matteson EL (2008) All medical eponyms should be abandoned. Presse Med 37(2 Pt 1):250–251

    Article  PubMed  Google Scholar 

  6. Gemmill CL (1972) The Greek concept of diabetes. Bull N Y Acad Med 48(8):1033–1036

    PubMed  PubMed Central  CAS  Google Scholar 

  7. Lindholm J (2004) Diabetes insipidus: historical aspects. Pituitary 7(1):33–38

    Article  PubMed  CAS  Google Scholar 

  8. Robertson GL (1983) Thirst and vasopressin function in normal and disordered states of water balance. J Lab Clin Med 101:351–371

    PubMed  CAS  Google Scholar 

  9. Prentice M (2018) Time for change: renaming Diabetes Insipidus to improve patient safety. Clin Endocrinol (Oxf) 88(5):625–626

    Article  Google Scholar 

  10. Atila C, Loughrey PB, Garrahy A, Winzeler B, Refardt J, Gildroy P, Hamza M, Pal A, Verbalis JG, Thompson CJ, Hunter SJ, Sherlock M, Levy MJ, Karavitaki N, Newell-Price J, Wass JAH, Christ-Crain M (2022) Central diabetes insipidus from a patients’ perspective: management, psychological co-morbidities, and re-naming of the condition. Lancet Diabetes Metab. https://doi.org/10.1016/S2213-8587(22)00219-4

    Article  Google Scholar 

Download references

Acknowledgements

The Working Group for Renaming Diabetes Insipidus: Hiroshi Arima for the Japanese Endocrine Society; Daniel Bichet for the American Society of Nephrology; Timothy Cheetham for the European Society for Paediatric Endocrinology; Mirjam Christ-Crain and Mark Gurnell for the European Society of Endocrinology; Julianna Drummond for the Brazilian Endocrine Society; Miles Levy and Mark Gurnell for the Society for Endocrinology; Ann McCormack for the Endocrine Society of Australia; Joe Verbalis and John Newell-Price for the Endocrine Society; John Wass for the Pituitary Society.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, 466-8550, Japan

    Hiroshi Arima

  2. University of Montreal, Montreal, QC, H3T 1J4, Canada

    Daniel G. Bichet

  3. Hôpital du Sacré-Coeur de Montréal, Montreal, QC, H4J 1C5, Canada

    Daniel G. Bichet

  4. Newcastle University, Newcastle Upon Tyne, NE1 7RU, UK

    Timothy Cheetham

  5. Great North Children’s Hospital (GNCH), Newcastle Upon Tyne, NE1 4LP, UK

    Timothy Cheetham

  6. Department of Endocrinology, University Hospital and University of Basel, 4031, Basel, Switzerland

    Mirjam Christ-Crain

  7. Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, CEP 31270-901, Brazil

    Juliana Drummond

  8. Wellcome-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke’s Hospital, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK

    Mark Gurnell

  9. Department of Endocrinology, University Hospitals of Leicester NHS Trust, Leicester, LE3 9QP, UK

    Miles Levy

  10. Department of Endocrinology, St Vincent’s Hospital, Sydney, NSW, 2010, Australia

    Ann McCormack

  11. Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia

    Ann McCormack

  12. St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, 2052, Australia

    Ann McCormack

  13. Department of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK

    John Newell-Price

  14. Georgetown-Howard Universities Center for Clinical and Translational Science, Georgetown University, Washington, DC, 20007, USA

    Joseph G. Verbalis

  15. Department of Endocrinology, Churchill Hospital, University of Oxford, Oxford, OX3 7LE, UK

    John Wass

  16. PricewaterhouseCoopers LLP, 7 More London Riverside, London, SE1 2RT, UK

    Deborah Cooper

Authors
  1. Hiroshi Arima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel G. Bichet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy Cheetham
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mirjam Christ-Crain
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juliana Drummond
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mark Gurnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Miles Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ann McCormack
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. John Newell-Price
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Joseph G. Verbalis
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. John Wass
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Deborah Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors wrote and reviewed the commentary.

Corresponding author

Correspondence to John Wass.

Ethics declarations

Competing interests

All the authors declared that they have no conflict of interest.

Ethical approval

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The members of the Working Group for Renaming Diabetes Insipidus are listed in Acknowledgement section.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arima, H., Bichet, D.G., Cheetham, T. et al. Changing the name of diabetes insipidus. Pituitary 25, 777–779 (2022). https://doi.org/10.1007/s11102-022-01276-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-022-01276-2

Search

Navigation